Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 22337714

Excess mortality after treatment with fludarabine and cyclophosphamide in combination with alemtuzumab in previously untreated patients with chronic lymphocytic leukemia in a randomized phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2012 May 31
First author
Lepretre S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2012 May 31;119(22):5059-60. doi: 10.1182/blood-2012-04-413096.
    note
    Source null
    related pmid
    22653949
    relationship
    Comment in

Authors and identifiers

  1. name
    Lepretre S
    type
    Author
  2. name
    Aurran T
    type
    Author
  3. name
    Mahé B
    type
    Author
  4. name
    Cazin B
    type
    Author
  5. name
    Tournilhac O
    type
    Author
  6. name
    Maisonneuve H
    type
    Author
  7. name
    Casasnovas O
    type
    Author
  8. name
    Delmer A
    type
    Author
  9. name
    Leblond V
    type
    Author
  10. name
    Royer B
    type
    Author
  11. name
    Corront B
    type
    Author
  12. name
    Chevret S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Lepretre S
    type
    Author
  2. name
    Aurran T
    type
    Author
  3. name
    Mahé B
    type
    Author
  4. name
    Cazin B
    type
    Author
  5. name
    Tournilhac O
    type
    Author
  6. name
    Maisonneuve H
    type
    Author
  7. name
    Casasnovas O
    type
    Author
  8. name
    Delmer A
    type
    Author
  9. name
    Leblond V
    type
    Author
  10. name
    Royer B
    type
    Author
  11. name
    Corront B
    type
    Author
  12. name
    Chevret S
    type
    Author
bibliography ids
  1. nci-bib-4ea5de2c6eb3c8fc709782df
book metadata
content sha256
29e3348643ab60e33073474e0502d226c18fb4ebc4172430dd8cf0550bb87e9d
document type
citation
dois
  1. 10.1182/blood-2011-07-365437
electronic publication date
display
2012 Feb 14
precision
day
year
2012
evidence scope
bibliographic_metadata_only
id
pubmed:22337714
immutable id
pubmed:22337714@29e3348643ab60e33073474e0502d226c18fb4ebc4172430dd8cf0550bb87e9d
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
22
name
Blood
nlm unique id
7603509
pages
5104-10
volume
119
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2012 May 31;119(22):5059-60. doi: 10.1182/blood-2012-04-413096.
    note
    Source null
    related pmid
    22653949
    relationship
    Comment in
outcomes validated
false
pmid
22337714
provenance
batch id
b6284687e167e7da9556
provider
NCBI PubMed ESummary
record sha256
aff4ed3dd157aa044f9c590c14677be53d1ad2250e1714e1015e1b88f8db8340
response sha256
64d5b7bb63f574c559af2523b779a262267cbc8e8cd02a5b47f4193cc95cabd3
retrieved at
2026-09-09T23:46:45.216259+00:00
publication date
display
2012 May 31
precision
day
year
2012
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/22337714/
title
Excess mortality after treatment with fludarabine and cyclophosphamide in combination with alemtuzumab in previously untreated patients with chronic lymphocytic leukemia in a randomized phase 3 trial.

Preserved source evidence · Not medical advice